Hunter Shkolnik Comments on Proposed Opioid Settlement
December 5, 2019
Source: Daily Stock Dish
Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.
The deal is “overvalued to make the settlement look better,” said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300 federal lawsuits consolidated in the U.S. District Court in Cleveland.
“I don’t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,” he told Reuters.
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.
Download
Featured Attorneys
Related Articles
What is Erb’s Palsy and How Is It Caused?
March 24, 2022
Newborns are incredibly vulnerable individuals. Many newborn babies don’t weigh much more than a two-liter bottle of soda. Excessive force on a baby’s arm or head usually causes Erb’s palsy, which affects the brachial plexus nerve bundle under the arms. Usually, this excessive force occurs during difficult deliveries, as outlined below. Like many other palsies…Read the article
Marie Napoli on News12 LI: Biomonitoring for Westhampton
March 21, 2017
Marie Napoli recently appeared on News12 Long Island in order to discuss the health risks associated with contaminated well water in Westhampton, New York. Like most people living in Westhampton, resident and Napoli Shkolnik client, Jerome Liggon said he never questioned the quality of the water coming out of his tap. However as he told…Read the article